Skip to main content

Cellular and Molecular Therapies and Mechanisms of Endocrine Disorders

Guest Editors:
Dimiter Avtanski: Feinstein Institute for Medical Research, USA
Ramkumar Mohan: University of Michigan Medical School, USA


BMC Endocrine Disorders has published this Collection on Cellular and Molecular Therapies and  Mechanisms of Endocrine Disorders.

Currently, the therapeutic options for patients with endocrine disorders are very limited, ineffective, challenging to implement, and accompanied by adverse side effects. Advancing our understanding of the basic molecular mechanisms responsible for the pathophysiology of endocrine disorders will lead to the generation of better cellular and animal disease models, more efficient drugs, and novel cell- and gene-therapy protocols.

Meet the Guest Editors

Back to top

Dimiter Avtanski: Northwell Health, USA

Dr. Avtanski received his M.Sc. degree in Biology and Chemistry from Sofia University in Bulgaria and his Ph.D. degree from the Bulgarian Academy of Sciences in collaboration with Beth Israel Medical Center at Albert Einstein College of Medicine in New York City. Dr. Avtanski specialized at Leipzig University, Germany, and completed seven years of post-doctoral fellowships at the Johns Hopkins University School of Medicine in Baltimore, Maryland. His main research focuses on the connection between obesity, diabetes, carcinogenesis, and steroidogenesis. Dr. Avtanski serves as Associate Editor for the journals Molecular Medicine, BMC Endocrine Disorders, JoVE, and World Journal of Diabetes, and is an Editorial Board Member for several other scientific journals. He is actively reviewing and has multiple recognitions for his reviewing activity. Dr. Avtanski is a research mentor of rotating fellows from Lenox Hill Hospital, Hofstra University, Feinstein Institutes for Medical Research, and other schools.
 

Ramkumar Mohan: University of Michigan Medical School, USA

Ramkumar Mohan is currently working as a Research Investigator in the Department of Pediatrics. He completed his Ph.D. in 2016 in the lab of Xiaoqing Tang and postdoctoral training in the lab of Emilyn Alejandro, University of Minnesota (2016-2019) and in the lab of Arun Ananthram, University of Michigan (2019-2021). His research experiences include more than 10 years of working with neuroendocrine cells, namely - pancreatic islets and adrenal chromaffin cells. His long-term goal is to find novel modulators of hormone secretion from these cells by expanding our current understanding of pathways involved in cell development, communication, function, and plasticity under various disease states, including obesity and diabetes. 
 

About the collection

BMC Endocrine Disorders has published this Collection on important insights on the biology of endocrine disorders and novel cellular and molecular therapies.





Topics of interest included but were not restricted to:

• Studies elucidating basic molecular and cellular mechanisms of endocrine disorders using in vitro and in vivo models

• Studies describing cellular and molecular therapies of endocrine disorders: stem-cell and iPSC-derived cells for transplantation, in vivo gene editing, in vivo reprogramming, xenotransplantation, animal models, and clinical trials (including study protocols)

• iPSC endocrine disease modeling/drug screening

• Tissue engineering

  1. Diabetic nephropathy (DN) represents a microvascular complication of diabetes mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy only reduces risk factors and hemodialys...

    Authors: Aditya Mahardika Wahono, Titut Harnanik, Irma A. Pasaribu, Ronald Pratama Adiwinoto and Yohana Octavianda
    Citation: BMC Endocrine Disorders 2023 23:254
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cellular and Molecular Therapies and  Mechanisms of Endocrine Disorders" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.